"Cefodizime is a broad-spectrum, third-generation cephalosporin utilized for treating severe infections caused by susceptible bacteria. However, it is not currently authorized by the FDA for use in the United States. Its adverse effect profile is comparable to other third-generation cephalosporins, with the most common side effects being gastrointestinal or dermatological in nature."
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Search Results for " Cefodizime "
Cefodizime Related Products
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Cefodizime, pharmacopeial and non-pharmacopeial Cefodizime impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Cefodizime impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.